Comparison between Asston Pharmaceuticals IPO and PDP Shipping IPO.
Asston Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while PDP Shipping IPO is a SME Fixed Price proposed to list at BSE SME.
| Asston Pharmaceuticals IPO | PDP Shipping IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | Sun Capital Advisory Services Pvt.Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | JSK Securities & Services Pvt.Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Asston Pharmaceuticals IPO is up to ₹26.17 Cr whereas the issue size of the PDP Shipping IPO is up to ₹12.02 Cr. The final issue price of Asston Pharmaceuticals IPO is ₹123.00 per share and of PDP Shipping IPO is ₹135.00 per share.
| Asston Pharmaceuticals IPO | PDP Shipping IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹115.00 per share | |
| Issue Price (Upper) | ₹123.00 per share | |
| Issue Price (Final) | ₹123.00 per share | ₹135.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1000 shares |
| Fresh Issue Size | 21,28,000 shares | 8,90,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.17 Cr | up to ₹12.02 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,28,000 shares | 8,90,000 shares |
| Issue Size Total (Amount) | up to ₹26.17 Cr | up to ₹12.02 Cr |
Asston Pharmaceuticals IPO opens on Jul 09, 2025, while PDP Shipping IPO opens on Mar 10, 2025. The closing date of Asston Pharmaceuticals IPO and PDP Shipping IPO is Jul 11, 2025, and Mar 12, 2025, respectively.
| Asston Pharmaceuticals IPO | PDP Shipping IPO | |
|---|---|---|
| Anchor Bid Date | Jul 08, 2025 | |
| Issue Open | Jul 09, 2025 | Mar 10, 2025 |
| Issue Close | Jul 11, 2025 | Mar 12, 2025 |
| Basis Of Allotment (Tentative) | Jul 14, 2025 | Mar 13, 2025 |
| Initiation of Refunds (Tentative) | Jul 15, 2025 | Mar 17, 2025 |
| Credit of Share (Tentative) | Jul 15, 2025 | Mar 17, 2025 |
| Listing date (Tentative) | Jul 16, 2025 | Mar 18, 2025 |
| Anchor Lockin End date 1 | Aug 13, 2025 | |
| Anchor Lockin End date 2 | Oct 12, 2025 |
Asston Pharmaceuticals IPO P/E ratio is 17.83, as compared to PDP Shipping IPO P/E ratio of 11.89.
| Asston Pharmaceuticals IPO | PDP Shipping IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Asston Pharmaceuticals Limited Financial Information (Restated)Asston Pharmaceuticals Limited's revenue increased by 62% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
| PDP Shipping & Projects Limited Financial Information (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 68.76 | 99.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 50.66 | 68.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.83 | 11.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹104.70 Cr. | ₹40.15 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.56% | 39.62% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 51.25% | 50.04% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.68 | 0.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.90 | ₹11.36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 40.36% | 39.62% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Asston Pharmaceuticals IPO Retail Individual Investors (RII) are offered 7,46,000 shares while in PDP Shipping IPO retail investors are offered 7,46,000 shares. Qualified Institutional Buyers (QIB) are offered 4,25,000 shares in Asston Pharmaceuticals IPO and 0 shares in PDP Shipping IPO.
| Asston Pharmaceuticals IPO | PDP Shipping IPO | |
|---|---|---|
| Anchor Investor Reserveration | 6,35,000 shares | 0 shares |
| Market Maker Reserveration | 1,13,000 shares | 47,000 shares |
| QIB | 4,25,000 shares | 0 shares |
| NII | 3,22,000 shares | 4,45,000 shares |
| RII | 7,46,000 shares | 4,45,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 21,28,000 shares | 8,90,000 shares |
Asston Pharmaceuticals IPO subscribed 186.55x in total, whereas PDP Shipping IPO subscribed 1.01x.
| Asston Pharmaceuticals IPO | PDP Shipping IPO | |
|---|---|---|
| QIB (times) | 85.76x | |
| NII (times) | 353.14x | 0.14x |
| Big NII (times) | 424.47x | |
| Small NII (times) | 210.85x | |
| RII (times) | 172.06x | 1.88x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 186.55x | 1.01x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
